Introduced:
Jan 3, 2025
Congress.gov:
Bill Statistics
3
Actions
0
Cosponsors
1
Summaries
0
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Jan 3, 2025
Referred to the House Committee on Energy and Commerce.
Summaries (1)
Introduced in House
- Jan 3, 2025
00
<p><strong>Medical Innovation Acceleration Act of 2025</strong></p><p>This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.</p><p>The bill defines <em>noninvasive diagnostic device</em> as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.</p>
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Jan 3, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
Jan 3, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
Jan 3, 2025
Full Bill Text
Length: 1,805 characters
Version: Introduced in House
Version Date: Jan 3, 2025
Last Updated: Nov 12, 2025 6:28 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 88 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 88
To amend the Federal Food, Drug, and Cosmetic Act to exempt from
regulation as devices non-invasive diagnostic devices, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Biggs of Arizona introduced the following bill; which was referred
to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to exempt from
regulation as devices non-invasive diagnostic devices, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[H.R. 88 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 88
To amend the Federal Food, Drug, and Cosmetic Act to exempt from
regulation as devices non-invasive diagnostic devices, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Biggs of Arizona introduced the following bill; which was referred
to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to exempt from
regulation as devices non-invasive diagnostic devices, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Medical Innovation Acceleration Act
of 2025''.
SEC. 2.
DEVICES.
Section 201
(h) of the Federal Food, Drug, and Cosmetic Act (21
U.
(h) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 321
(h) ) is amended--
(1) by striking ``
section 520
(o) '' and inserting the
following: ``
(o) '' and inserting the
following: ``
section 520
(o) or any non-invasive diagnostic
device''; and
(2) by adding at the end the following: ``For purposes of
the preceding sentence, the term `non-invasive' means, with
respect to a diagnostic device, that the device does not
penetrate the skin or any other membrane of the body, is not
inserted or implanted into the body, causes no more than
ephemeral compression or temperature changes to in situ bodily
tissues, and does not subject bodily tissues to ionizing
radiation.
(o) or any non-invasive diagnostic
device''; and
(2) by adding at the end the following: ``For purposes of
the preceding sentence, the term `non-invasive' means, with
respect to a diagnostic device, that the device does not
penetrate the skin or any other membrane of the body, is not
inserted or implanted into the body, causes no more than
ephemeral compression or temperature changes to in situ bodily
tissues, and does not subject bodily tissues to ionizing
radiation.''.
<all>